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Abstract
Digital PCR (dPCR) is the gold standard analytical platform for rapid high precision
quantification of genomic fragments. However, current dPCR assays are generally
limited to monitoring 1-2 analytes per sample, thereby limiting the platform’s ability to
address some clinical applications that require the simultaneous monitoring of 20 – 50
analytes per sample. Here we present Virtual Partition dPCR (VPdPCR), a novel
analysis methodology enabling the detection of 10 or more target regions per color
channel using conventional dPCR hardware and workflow. Furthermore, VPdPCR
enables dPCR instruments to overcome upper quantitation limits caused by partitioning
error. While traditional dPCR analysis establishes a single threshold to separate
negative and positive partitions, VPdPCR establishes multiple thresholds to identify the
number of unique targets present in each positive droplet based on fluorescent intensity.
Each physical partition is then divided into a series of virtual partitions, and the
resulting increase in partition count substantially decreases partitioning error. We
present both a theoretical analysis of the advantages of VPdPCR and an experimental
demonstration in the form of a 20-plex assay for non-invasive fetal aneuploidy testing.
This demonstration assay – tested on 432 samples contrived from sheared cell-line DNA
at multiple input concentrations and simulated fractions of euploid or trisomy-21 “fetal”
DNA – is analyzed using both traditional dPCR thresholding and VPdPCR. VPdPCR
analysis significantly lowers variance of chromosome ratio across replicates and increases
the accuracy of trisomy identification when compared to traditional dPCR, yielding
>98% single-well sensitivity and specificity. VPdPCR has substantial promise for
increasing the utility of dPCR in applications requiring ultra-high-precision
quantitation.
Introduction 1
In many clinical diagnostic applications, it is essential to not only detect the presence of 2
a nucleic acid target, but to also measure its concentration. This is commonly done 3
with the quantitative polymerase chain reaction (qPCR), which calculates concentration 4
based on the number of PCR cycles needed for a sample to reach a certain signal 5
threshold. This method benefits from widespread instrument deployment and a simple 6
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workflow, but requires running standards for calibration purposes and is only effective 7
at establishing target concentration within a factor of 2 [1–3]. 8
An alternative approach to target quantitation is digital PCR (dPCR). dPCR 9
divides a sample into tens of thousands of individual partitions prior to amplification. 10
After amplification, the partitions that generate an amplification signal are counted to 11
produce measurements of target concentration. When compared to qPCR, dPCR 12
improves both precision and low-copy sensitivity, while providing absolute quantitation 13
without the need for calibrating standards [1–4]. Due to its advantages, dPCR has 14
shown increasing utility in a number of diagnostic applications, including absolute 15
quantification of viral load, analysis of circulating DNA, gene and microRNA expression, 16
and analysis of gene copy number variation [5–9]. 17
The most fundamental limit to the precision of dPCR quantitation is Sampling 18
Variance; if the true mean number of target copies across many sample replicates is N , 19
the standard deviation of the number of copies truly present in each replicate will be 20√
N [10] (Figure 1a). For applications that require high precision at low input copy 21
numbers, this level of variance can be unacceptably high. The number of effective 22
sample copies can be increased by multiplexing, i.e. designing multiple assays specific to 23
different regions of the target. However, as the number of effective sample copies passes 24
the number of physical partitions the partitions become oversaturated, leading to high 25
levels of Partitioning Variance [10]. This tradeoff, illustrated in Figure 1b, has limited 26
the usefulness of multiplexing for decreasing Sampling Variance in single-well dPCR 27
assays [5]. 28
The statistical analysis underlying the red line in Figure 1b assumes traditional 29
dPCR analysis, which uses a single amplitude threshold to classify each partition as 30
either negative for all targets or positive for at least one target. One way around this 31
Partitioning Variance limitation is to apply enhanced assay design to generate multiple 32
distinct signal clusters corresponding to different combinations of target regions in the 33
partitions. Historically this process has proven difficult, limiting such multiplexing 34
applications to 2 or 3 targets per optical color channel [11–15]. However, this difficulty 35
can be overcome by applying High Definition PCR (HDPCRTM ), a recent innovation in 36
qPCR technology, which has been used to expand the multiplexing capacity of qPCR 37
instruments [16]. In this paper we describe Virtual Partition dPCR (VPdPCR), a 38
method which leverages HDPCR and a novel analysis technique to enable significantly 39
higher levels of multiplexing on existing dPCR instruments using standard TaqMan 40
chemistries. We present both a theoretical analysis of the advantages of VPdPCR and 41
an experimental demonstration of its capabilities in the form of a single-well, 20-plex 42
assay for detection of fetal chromosomal aneuploidies. 43
Virtual Partition dPCR 44
VPdPCR combines multiple TaqMan® assays that are designed to detect multiple 45
distinct regions of the desired target, in this case a particular chromosome. The 46
TaqMan probes for all target regions on a given chromosome are labeled with the same 47
fluorophore and quencher pair, and they are all titrated to generate the same 48
fluorescence intensity if the target region is present. These probes generate signals that 49
add linearly in combination; if a single target region generates fluorescence intensity I 50
when it is present in a partition, a partition with n distinct target regions will have 51
fluorescence intensity n ∗ I. The number of target regions presents in each partition can 52
thus be inferred solely from the signal intensity measurement of the partition. 53
In traditional dPCR analysis, a single signal intensity threshold is drawn to separate 54
partitions positive for 1 or more target regions from those partitions negative for all 55
target regions. VPdPCR changes the readout of a digital partition from a 2 state 56
system to a T + 1-state system by drawing T different intensity thresholds, where T is 57
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Fig 1. Digital PCR mathematical noise floor The coeffecient of variation (CV)
of calculated copies per reaction across a range of expected copies in sample, assuming a
digital PCR reaction with 20,000 physical partitions. The dashed grey line represents
7,000 copies per reaction with only one assay per target, while the dotted grey line
represents 70,000 effective copies corresponding to assays for 10 unique target regions on
each of 7,000 target copies. a) Sampling Variation: The standard deviation due to
sampling error is defined as the square-root of the mean expected copies in a sample.
This error is independent of the analysis method. Increasing the number of assays per
target effectively increases the expected number of copies and decreases the Sampling
Variance. b) Partitioning Variation: The standard deviation due to partitioning error is
dependent on the number of partitions a sample is divided into. The VPdPCR assay
(blue) described in this paper increases the effective number of partitions 10-fold,
significantly reducing the mathematical noise floor due to partitioning error when
compared with the tradition threshold method (red).
the number of target regions and 1 is added for the negative state (Figure 2). Each 58
partition is divided into T ”virtual partitions”, enabling higher allowable target 59
concentrations without oversaturation by increasing the number of effective partitions 60
by a factor of T. Creating these virtual partitions significantly reduces the Partitioning 61
Variance which usually occurs as the occupancy of the physical partitions approaches 62
100% (Figure 1b, blue curve). 63
This manuscript presents a demonstration assay capable of detecting 10 unique 64
target regions per channel, with one channel devoted to targets from chromosome 18 65
and the other dedicated to targets from chromosome 21 (Figure 3). By increasing the 66
effective target concentration, VPdPCR drives down Sampling Variance while avoiding 67
high Partitioning Variance caused by oversaturation (Figure 1). This allows for 68
consistent detection of very small differences in abundance ratio between the 69
chromosomes. To demonstrate the utility of the technique, we apply it to the problem 70
of differentiating simulated cell-free DNA (cfDNA) samples with and without small 71
fractions of trisomy 21 DNA. 72
Non-Invasive Fetal Aneuploidy Testing 73
Screening for fetal aneuploidy in expectant mothers is one of the most common forms of 74
prenatal diagnostics in the world [17], and is traditionally performed using methods 75
such as chorionic villus sampling or amniocentesis. While these tests still represent a 76
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Fig 2. Evolving Multiplex Digital PCR a) Traditional singleplex dPCR is a
robust method using a simple threshold but is limited by significant variation at low
input and high input due to sampling and Partitioning Variance respectively. b) By
combining VPdPCR with HDPCR we’re able to divide each partition into many bins to
determine the copies per virtual partition. This substantially reduces Partitioning
Variance by expanding the number of effective partitions.
gold standard for accuracy, their invasive nature limits their application to high-risk 77
populations [18]. The discovery of fetal cell-free DNA (cfDNA) circulating in maternal 78
blood [19] opened the door to non-invasive prenatal testing (NIPT) for fetal aneuploidy 79
by counting chromosomal copies; if a fetus is triploid for a given chromosome, the 80
number of copies of that chromosome in fetal cfDNA should be 50% higher than all 81
other copy numbers. Modern fetal aneuploidy tests are often performed via 82
next-generation sequencing or microarray tests which require expensive equipment and 83
consumables as well as complicated multi-day workflows, largely relegating them to 84
centralized laboratories and driving up costs. 85
dPCR provides lower cost, lower complexity, and higher throughput when compared 86
to NGS or microarray tests, making it a desirable modality for fetal aneuploidy 87
screening. However, no single well dPCR-based assay for NIPT has come to market [20]. 88
The primary reason is limited precision; for a euploid mother and an aneuploid fetus 89
with a trisomy only the fetal portion of the cfDNA will show an excess in chromosomal 90
copies, and the fraction of fetal cfDNA derived from a maternal blood or plasma sample 91
can be as low as 4% [21]. This results in only a 2% excess of the fetal trisomy 92
chromosome amongst the whole cfDNA sample, and standard single target dPCR assays 93
are unable to distinguish maternal from fetal DNA. As a result, attempting to 94
consistently measure the excess of the fetal trisomy chromosome using single-plex dPCR 95
proves especially difficult due to Sampling Variance. 96
Multiple groups have attempted to use multiplexing to bypass this Sampling 97
Variance problem [22–24]. However, in order to avoid oversaturation, these assays must 98
increase the number of effective partitions by either splitting each sample across 8 or 99
more wells [22,24] or using specialized (and now-discontinued) platforms that can 100
generate millions of partitions per sample [23]. Both of these approaches increase cost 101
and decrease throughput. We instead apply VPdPCR to increase the number of 102
effective partitions, thereby substantially improving accuracy of quantitation at higher 103
target concentrations than was previously possible in a single-well assay. While the 104
presented results are only intended as a proof of concept, they establish the power of 105
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Fig 3. Virtual Partition dPCR data a) Two dimensional plot of experimental
VPdPCR data with 7000 haploid genomic copies in 20,000 physical partitions. The
assay was designed with 10 independent target regions per chromosome, with chr18
target regions in channel 1 and chr21 target regions in channel 2. Thanks to HDPCR,
distinct point clusters can be discerned containing droplets with different numbers of
target regions. The color of the individual points represents the intensity of channel 1
and channel 2 as the Green and Red component of RGB values respectively. The purple
box encompasses the partitions that can be analyzed with standard dPCR thresholding,
while the green box encompasses the additional virtual partitions which can be
interrogated in a 10 target per channel VPdPCR assay. b) Probability density function
(PDF) plots for channel 1 and channel 2 of the experimental data from the same
reaction. Each channel’s PDF is analyzed independently to calculate copies of each
chromosome. In both plots the solid grey line represents the traditional threshold
between positive and negative physical partitions, while the dashed grey lines separate
the virtual partitions differentiated by signal intensity.
VPdPCR as a potential foundation for future ultra-high-precision quantitative assays. 106
Glossary 107
• Target: the whole nucleic acid molecule of which the concentration is being 108
interrogated. Examples: a whole genome, an individual chromosome, a particular 109
RNA transcript. 110
• Target Region: a sub-sequence within the complete Target sequence which is 111
detected by a unique assay. Example: the template region of a Target for a PCR 112
detection assay. 113
• Partition: one of many independent physically separate PCR reactions into which 114
a sample is equally divided in dPCR. Examples: A individual droplet or 115
microfluidic well. 116
• Virtual partition: Expanded partitions derived from the signal amplitude when 117
multiple Target Region assays are leveled to produce the same signal intensity. 118
Example: in an assay with 10 Target Regions to interrogate a single Target, every 119
physical partition is divided into 10 virtual partitions using the VPdPCR method. 120
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• Classification: Analyzing a partition and determining how many positive targets it 121
contains based on its signal amplitude. Examples: identifying a partition as 122
positive or negative in traditional dPCR, or placing it into a bin level 0 through T 123
in VPdPCR. 124
• Positive Partition Count: the total number of positive partitions identified after 125
classification. Examples: The sum of positive physical partitions in traditional 126
dPCR or the sum of positive virtual partitions in VPdPCR. 127
• Target Region Copies: the computed total number of target regions present in a 128
sample after obtaining a Positive Partition Count and applying Poisson statistics. 129
Example: Chr18 Copies is the imputed total number of target regions from 130
chromosome 18 present in the original sample. 131
• Sampling Variance: The variation the number of targets which actually end up in 132
a reaction due the sub-sampling of a larger population. This has larger effect on 133
low concentration sample accuracy due to the standard deviation being
√
m where 134
m is the expected number of targets [25]. 135
• Partitioning Variance: The variance attributed to the distribution of targets 136
between the partitions. At high concentrations the number of empty partitions 137
the standard deviation
√
E(1− E)/n where E is the proportion of negative 138
partitions and n is the number of partitions [10]. 139
Results and Discussion 140
We contrived 432 cell line-based DNA samples, each consisting of a mixture of 141
”maternal” euploid DNA from a wild type cell line and simulated ”fetal” DNA from 142
either a trisomy 21 cell line or a different euploid cell line. Half of the samples contained 143
7000 total copies of chr18 and half of the samples contained 3500 copies – both of which 144
are representative of DNA concentrations in a typical cell-free DNA extraction from 145
expectant women [26]. Within each of these sets, 36 samples each had simulated 146
aneuploid trisomy 21 fetal fractions of 0%, 5%, 10%, and 20%, and 36 samples each had 147
simulated euploid fetal fractions of 5% and 100%. Two of the 20% simulated aneuploid 148
fetal fractions wells at 7000 input copies had failures in the droplet reader and results 149
were discarded. Summary results are shown below in Table 1 with all euploid samples 150
condensed into one row, and these euploid samples are broken out by cell line 151
composition in Table 2. An unexpected result is that even in the purely euploid samples 152
the chr21 counts are 4.9% higher than chr18 counts on average. There are multiple 153
possible explanations for this, including off-target amplifications, a duplicated target 154
region on chr21, or chr18 target regions being more susceptible to shearing during 155
sample preparation. Fortunately, this excess is consistent across all euploid sample 156
compositions and the difference in ratios between this baseline and other experimental 157
conditions (∆Ratio in the table) scales as expected with aneuploid fraction, indicating 158
that this is a consistent offset across all samples. Thus, when classifying samples to 159
identify fetal trisomy we treat 1.049 as the baseline euploid chromosome ratio. 160
Receiver operating characteristic (ROC) analysis was performed on the complete 161
data set to identify the optimal threshold to separate trisomy 21 spiked samples from 162
the euploid samples using the ratio of Chr21/Chr18 as the predictor. The calculations 163
were performed using the R software package pROC [27,28]. The optimal threshold was 164
determined to be 1.0672 (Figure 4). 165
In the tables above σRatio, or the standard deviation of calculated chromosome ratio 166
across all replicates, is the most important metric for determining the level of 167
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VPdPCR Analysis Threshold Analysis
λChr18 λChr21 Ratio* ∆Ratio σRatio Accuracy σRatio Accuracy
7k Haploid Genomic Copies per Well
0%** 108 0.2666 0.2794 1.048 -0.1% 0.86% 98.1% 1.46% 85.1%
5% 36 0.2658 0.2864 1.078 2.9% 0.83% 97.2% 1.72% 77.8%
10% 36 0.2641 0.2912 1.103 5.4% 0.67% 100% 1.58% 100%
20% 34 0.2632 0.3037 1.154 10.5% 0.86% 100% 1.51% 100%
3.5k Haploid Genomic Copies per Well
0%** 108 0.1325 0.1390 1.049 0.0% 1.02% 98.1% 1.28% 87.0%
5% 36 0.1330 0.1435 1.080 3.1% 0.95% 88.9% 1.39% 86.1%
10% 36 0.1337 0.1475 1.103 5.4% 0.80% 100% 1.33% 100%
20% 36 0.1327 0.1532 1.154 10.5% 1.10% 100% 1.48% 100%
*λChr21/λChr18
**Includes the three euploid only Cell line DNA mixtures from the Table 2: Contrived Euploid Pregnancy Results.





VPdPCR Analysis Threshold Analysis
λChr18 λChr21 Ratio* ∆Ratio σRatio Accuracy σRatio Accuracy
7k Haploid Genomic Copies per Well
0% 36 0.2666 0.2794 1.048 -0.1% 0.82% 100% 1.16% 88.8%
5% 36 0.2633 0.2764 1.050 0.1% 1.00% 94.4% 1.13% 88.8%
100% 36 0.2699 0.2823 1.046 -0.3% 0.70% 100% 1.91% 77.8%
3.5k Haploid Genomic Copies per Well
0% 36 0.1310 0.1376 1.050 0.1% 1.12% 94.4% 1.37% 80.6%
5% 36 0.1317 0.1388 1.054 0.5% 0.72% 100% 1.09% 88.8%
100% 36 0.1347 0.1408 1.045 -0.4% 0.97% 100% 1.36% 91.7%
*λChr21/λChr18
quantitative accuracy the assay has achieved. A lower σRatio indicates that the assay is 168
more able to precisely identify the true ratio of chromosomes present in the sample, 169
thereby increasing its accuracy in high-precision applications like fetal trisomy testing. 170
Tables 1 and 2 compare σRatio when samples were analyzed using VPdPCR 171
(Equation 2) versus the traditional method (Equation 1). The traditional analysis was 172
conducted using sample-specific positive/negative amplitude thresholds for each well by 173
taking the midpoint of the fitted 0-target and 1-target peaks in each channel. Even with 174
this optimized thresholding, the VPdPCR analysis consistently achieved lower σRatio on 175
every set of replicates when compared to traditional analysis. This difference was most 176
pronounced for 7k input samples, where VPdPCR cut σRatio by more than a factor of 2 177
in some cases. For 3.5k input samples we expect VPdPCR to provide less of an 178
advantage, as partitioning error is less pronounced at lower input concentrations due to 179
less oversaturation. This theory is reflected in the results, which show a smaller but still 180
consistent improvement from applying VPdPCR in these samples. The differences in 181
ratio distributions from the two analyses are shown visually in Figure 5. 182
Table 1 show the accuracy of our assay when applying the ROC-optimized threshold 183
to separate euploid from aneuploid samples. 0% simulated fetal fractions samples were 184
called correct if the computed chr21/chr18 ratio fell below the ROC-threshold, and all 185
other samples were called correct of their ratio fell above the threshold. As shown in 186
Figure 5 the ratio distributions for 0% and 5% simulated fetal fractions overlap 187
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Fig 4. Receiver operating characteristic curve. ROC curves generated using a)
the traditional threshold method and b) VPdPCR method. Both ROC curves use the
the complete data set including all fetal fractions and both starting concentrations to
determine the optimal threshold to separate the pure euploid from trisomy 21 spiked
samples.
significantly less when VPdPCR analysis is applied, and this is reflected in the accuracy 188
results; VPdPCR consistently classifies samples with higher accuracy than traditional 189
analysis does. It is worth emphasizing that this data represent a proof of concept for 190
the VPdPCR technique and are not intended to demonstrate clinical viability. This 191
proof of concept demonstrates that VPdPCR has substantial promise for increasing the 192
utility of digital PCR in applications like fetal trisomy screening requiring 193
ultra-high-precision quantitation. 194
Materials and methods 195
Novel dPCR Analysis: Multi-Gaussian Fitting 196
In dPCR analysis the goal is to determine the number of copies per partition of each
target, denoted by λ. For multi-channel assays, if we assume targets are independently
distributed we can treat each channel independently and thereby compute a separate λ
for each channel; this approach is taken for all presented analyses (Figure 3b). The
distribution of each target amongst all partitions is dictated by Poisson statistics, which
specify that the probability of a partition being negative for a target with concentration
λ is simply pneg = e
−λ. In traditional single-target dPCR analysis a single amplitude
threshold is drawn to separate positive from negative partitions, and target
concentration (in copies per partition) is calculated as λ = − ln (pneg) (where pneg is the
fraction of partitions below the threshold). If T targets are present at identical
concentrations these equations become
pneg = e
−Tλ
λ = − 1
T
ln(pneg) (1)
In real experiments, the precision with which we can determine pneg is limited by the 197
number of negative partitions, with fewer negative partitions leading to higher variance. 198
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Fig 5. Ratio of Chromosome 21 to Chromosome 18. The ratio Chr21 to Chr18
across a range of euploid and trisomy 21 DNA spiked into euploid background DNA
using both the traditional threshold (red) and virtual partition (blue) analysis methods.
a) Samples spiked with a T21 cell-line DNA into a euploid background with 7000
haploid genomic equivalents of chromosome 18 per reaction. b) Samples spiked with a
T21 cell-line DNA into a euploid background with 3500 haploid genomic equivalents of
chromosome 18 per reaction. c) Samples spiked with a euploid cell-line DNA into a
different euploid cell-line background with 7000 haploid genomic equivalents of
chromosome 18 per reaction. d) Samples spiked with a euploid cell-line DNA into a
different euploid cell-line background with 3500 haploid genomic equivalents of
chromosome 18 per reaction.
In the box and whiskers plots the center line corresponds to the median, the lower and
upper boxes represent the first and third quartiles respectively, and the whiskers extend
from the boxes to the smallest and largest values no further from the median than 1.5
times the inter-quartile range. Outlier data beyond the whiskers is represented by
individual points and the notch within the boxes approximates the 95% confidence
interval of the median. The dashed line is the optimal threshold of 1.0672 as determined
by ROC analysis for all samples using the VPdPCR method. Plots were generated with
the R software package ggplot2 [29].
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This is what leads to the oversaturation effect described earlier. For example, if T = 10 199
and λ = 1 we get pneg ≈ 5× 10−5, which corresponds to only a single negative partition 200
on average in a 20,000 partition system. This leads to extremely high errors with 201
traditional analysis, necessitating new analysis techniques in such a regime. 202
To perform more accurate analysis, we need to identify how many of the T targets 203
are present in each partition rather than merely determining whether or not the 204
partition is negative for all targets. This can be done by dividing up the amplitude 205
range of our partitions into bins with indices t = 0, 1, . . . , T . Once bin boundaries are 206
determined, the number of targets present in each partition can be counted by simply 207
determining which boundaries its amplitude falls in between. In principle, on a perfectly 208
consistent system one could run calibration wells and manually draw boundaries 209
between all peaks, then apply those boundaries to sample data. However, on real data, 210
peak locations vary from sample to sample due to a combination of instrument and 211
pipetting variance, leading to poor performance with fixed bin boundaries. 212
We instead use a more robust method of multi-peak fitting which takes advantage of
two observed properties of the system: 1) each peak in the probability density function
(PDF) of partition amplitudes can be well approximated by a Gaussian function(
Gt(x) = At ∗ e−(x−µt)
2/2σ2t
)
, and 2) peak amplitudes add linearly, with equal spacing
between each subsequent pair of peaks. The fit is based on 5 free parameters: Target
Region Copies per droplet (λ, assumed to be the same for all target regions on a
chromosome); centers of the 0-target and 1-target bins (µ0 and µ1); and widths of the
0-target and 1-target bins (σ0 and σ1) The linearity of the system allows us to
determine the center and width of all subsequent peaks:
µt = µ0 + t ∗ (µ1 − µ0)
σ2t = σ
2




We can also determine the heights of all peaks based off of 1) Poisson statistics that
dictate the probability P (t) of a partition containing t target regions and 2) the fact
















Once we have calculated µ, σ, and A for every peak we construct a full predicted PDF
by adding all of the Gaussian functions together (Figure 6a). The optimal set of
(λ, µ0, µ1, σ0, σ1) is determined to be the one which minimizes the RMS error between
the full predicted PDF and the observed PDF. This fit is then used to determine n(t),
the total number of partitions in each bin. Rather than assigning each one of the N
total partitions to a single bin, we divide it between bins based on the relative
magnitude of each bin’s Gaussian at the partition’s amplitude (xi), improving
classification accuracy for higher-order bins in which the tails of neighboring Gaussians






Creating Virtual Partitions 213
Once n(t) has been determined for all bins we use it to calculate target copies. To do 214
this we divide each of our N total partitions into T ”virtual” partitions, of which t are 215
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Fig 6. Multi-Gaussian Fitting. Rather than analyzing droplet amplitudes using a
traditional positive/negative cutoff threshold (dashed black lines), using VPdPCR we fit
the whole amplitude distribution to an extrapolated series of Gaussian functions (red
lines). a) Our model matches the observed distribution well in a contrived cfDNA
sample with significant peaks up to level 5. b) In a very high-concentration sample
there is no 0-target peak, so traditional threshold analysis would fail completely.
However, our multi-Gaussian fitting method is still able to perform an appropriate fit
and thereby extract target concentration using VPdPCR analysis.
positive and T − t are negative. This effectively transforms our T -target sample with N 216
partitions into a 1-target sample with T ∗N partitions. We then count the negative 217
virtual partitions and apply our formula from above to get target concentration: 218















This formulation uses information from all bins 0 through T rather than just bin 0, 219
allowing for accurate analysis at higher concentrations where few partitions are negative 220
for all targets. As shown in Figure 6b this method even works when no droplets are 221
present in the 0-target bin, a regime in which traditional threshold-based analysis 222
breaks down completely. 223
Theoretical Error Limits 224
Before experimentally evaluating the VPdPCR assay, we first determined theoretical 225
optimum performance under different levels of multiplexing. For fetal trisomy testing 226
the relevant analysis output is not the absolute number of copies of any one target but 227
rather the ratio between total copies from one chromosome and total copies from 228
another chromosome. The goal is to be able to consistently distinguish between a 229
chromosome ratio of 1 (corresponding to a euploid mother and fetus) and a higher ratio 230
corresponding to a euploid mother and fetus with a trisomy. Detailed statistical analysis 231
by Dube et al [10] allows us to obtain 95% confidence intervals for calculated 232
chromosome ratios given various true input ratios and partition counts. Figure 7a shows 233
these confidence intervals for 20,000 partitions given simulated samples with a euploid 234
fetus and a triploid fetus with a 5% fetal fraction in extracted cfDNA. At 7000 input 235
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genomic copies the intervals significantly overlap, indicating that a traditional assay 236
with 1 target per chromosome cannot consistently identify fetal trisomy at a fetal 237
fraction of 5%. If we increase the number of target regions per chromosome but 238
maintain traditional threshold-based analysis we can effectively increase the input 239
genomic copies without changing the number of partitions. However, as the graph 240
shows, there is no input value for which the intervals are non-overlapping, indicating 241
that no amount of multiplexing can make this task possible with threshold analysis. 242
Fig 7. Theoretical Confidence Intervals. To consistently distinguish a diploid
from a triploid fetus at a 5% fetal fraction in cfDNA, the two confidence intervals shown
should be non-overlapping. a) With a singleplex assay on a machine with 20k physical
partitions there is substantial overlap at 7k input copies. Multiplexing with traditional
analysis is equivalent to a singpleplex assay with more input copies (red line), but no
value of input copies produces non-overlapping intervals. b) Our
10-plex-per-chromosome VPdPCR assay expands the number of effective partitions,
creating an input copy region with non-overlapping intervals and making it theoretically
viable for fetal aneuploidy testing.
The conventional limitations of traditional threshold analysis changes significantly 243
when we apply multi-Gaussian fitting and VPdPCR analysis to encompass all peaks in 244
multiplexed reactions rather than simple positive/negative classification, which increases 245
both the input copy number and the number of virtual partitions by a factor equal to 246
the number of target regions per chromosome. Figure 7b-d shows the effect of this 247
enhanced multiplexing on chromosome ratio confidence intervals. We found that 10 248
targets per chromosome is just enough to get theoretically consistent distinction 249
between diploid and triploid samples at 5% fetal fraction and 7k input copies, so we 250
chose that as the target of our assay design. 251
Digital PCR Assay Design 252
Multiple TaqMan® PCR assays were designed to amplify conserved regions of 253
Chromosomes 18 and 21 using the Primer3 command line tool [30,31] with GNU 254
Parallel [32] to process designs efficiently on multiple computer cores. We also used 255
primer3 to calculate the binding energies of all pairwise dimers ([monovalent cation] = 256
50mM, [divalent cation] = 2.5mM, [dNTP] = 0.8 mM, temperature = 60°C), and assays 257
were removed to eliminate favorable oligo-oligo interactions until we reached 10 assays 258
per chromosome. The selected primers and probes were ordered from Integrated DNA 259
Technologies, Inc. (Coralville, IA). Chromosome 18 and 21 TaqMan probes were labeled 260
to be detected in dye channel 1 and channel 2 respectively, and both target 261
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chromosomes’ TaqMan probes were double quenched with ZENTM quenchers. . A 262
20-plex oligo mix was prepared with all the primers at equal concentration and probes 263
at a significantly lower concentrations. The assay is in development and has not been 264
officially released or approved by the U.S. Food & Drug Administration. 265
Sample Preparation 266
Cell line DNA stocks from the Coriell Institute for Medical Research (NA04965 267
(Trisomy 21), NA12878 (euploid), and NA15453 (euploid)) were sheared with a 268
Covaris® E220 Focused-ultrasonicator (SKU500239) in order to have a mean length of 269
150 base pairs, simulating the short fragments found in cfDNA. Sheared DNA was 270
processed through the standard singleplex ddPCR workflow using a chromosome 18 271
target to calculate concentration. To simulate presence of Trisomy 21 stocks were 272
diluted in 1x, low EDTA TE (Gbiosciences 786-151) to a total of 3500 copies/5 µL and 273
7000 copies/5 µL at 5%, 10% and 20% NA04965 in NA12878. To simulate euploid 274
samples the euploid cell lines were diluted to a total of 3500 copies and 7000 copies/5µl 275
at 0%, 5% and 100% NA15453 in NA12878. 276
Digital PCR Methods 277
PCR reactions were set up using the following volumes: 10 µL 2x ddPCR Supermix for 278
probes (no dUTP) (BioRad Laboratories© 186-3024), 5 µL of 20plex oligo mix, and 5 279
µL of sample. 15 µL of PCR mix was added to each well of 96 well ddPCR plate 280
(BioRad Laboratories 12001925) followed by 5 µL of each sample. Plates were sealed 281
using pierceable foil heat seal (BioRad Laboratories 1814040) and the PX1 plate sealer 282
(BioRad Laboratories 1814000). Plates were vortexed, spun down, and run on the 283
Automated Droplet Generator (BioRad Laboratories 1864101) using Automated Droplet 284
Generation Oil for Probes (BioRad Laboratories 1864110) and the DG32™ Automated 285
Droplet Generator Cartridge (BioRad Laboratories 1864108). After droplet generation 286
was completed, thermocycling was performed on the C1000 Touch with the 96 deepwell 287
module (BioRad Laboratories 1840197). Thermocycling was performed as follows: 1. 288
Enzyme activation (95°C for 10 minutes), 2. 45 Cycles consisting of denaturation (95°C 289
for 20 seconds) followed by combined annealing/extension (58°C for 2 min), 3. Enzyme 290
deactivation (98°C for 10 minutes), and 4. A 4°C infinite hold. Signal detection was 291
performed on the QX200 Droplet Reader (BioRad Laboratories 1864001). Experiment 292
was set to ABS, Target 1 was set to Ch1 Unknown, Target2 was set to Ch2 Unknown 293
and Supermix was set to ddPCR Supermix for probes (no dUTP). Wells were read in 294
columns. Data was exported using the BioRad Laboratories QuantaSoft Version 295
1.7.4.0917 Software and analyzed using the Python Programming Language version 3.7 296
(Python Software Foundation, https://www.python.org/). 297
Conclusion 298
Digital PCR enables best-in-class rapid quantitative percision for monitoring genomic 299
fragments. However, dPCR on its own, is insufficient for some clinical diagnostic 300
applications, including non-invasive prenatal testing. VPdPCR method not only 301
enhances single-well dPCR multiplexing by a factor of 10 in this demonstration, but 302
also enables dPCR platforms to overcome fundamental limitations to precision by 303
decreasing both sampling and partition error. With newer multi-channel digital 304
platforms, VPdPCR could enable a complete aneuploidy panel for chromosomal 305
abnormalities (Chr21, Chr18, Chr13, X, Y) in a single well. We believe the enhanced 306
precision of VPdPCR could also be useful in a variety of other diagnostic settings, such 307
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as detecting copy number variation of crucial genes to perform liquid biopsies or 308
analyzing low abundance mRNA expression. This range of applications has the 309
potential to make VPdPCR a standard of practice for precision molecular diagnostics. 310
Supporting information 311
Table S1. Digital 20plex Processed Data Table Key
File Name: S1 vpdpcr processed data.csv
Column Name Key
run run number
well ind well id numeric 0 indexed
well name well location on 96 well plate
sample name sample name total DNA % spiked DNA
partition ind partition id numeric 0 indexed
ch1 amp partition raw fluorescence amplitude data for channel 1
ch2 amp partition raw fluorescence amplitude data for channel 2
qc pass individual partition quality control
well excluded wells labeled 1 excluded from analysis
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